Skip to main content
Journal of Experimental & Clinical Cancer Research : CR logoLink to Journal of Experimental & Clinical Cancer Research : CR
. 2023 Sep 30;42:257. doi: 10.1186/s13046-023-02824-9

Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma

Fei Teng 1,2,#, Ju-Xiang Zhang 3,#, Qi-Meng Chang 1,2, Xu-Bo Wu 1,2, Wei-Guo Tang 1,2, Jian-Fa Wang 1,2, Jin-Feng Feng 1,2, Zi-Ping Zhang 1,2,, Zhi-Qiu Hu 1,2,
PMCID: PMC10542228  PMID: 37775828

Correction: J Exp Clin Cancer Res 39, 235 (2020)

10.1186/s13046-020-01739-z

Following publication of the original article [1], incorrect Additional File 1 has been uploaded. The correct file replacement is now processed and uploaded.

The correction does not affect the overall result or conclusion of the article. The original article has been corrected.

Electronic supplementary material

Below is the link to the electronic supplementary material.

13046_2023_2824_MOESM1_ESM.pdf (221.7KB, pdf)

Table S1. Primers and oligonucleotides sequences used in this study.

Footnotes

The online version of the original article can be found at 10.1186/s13046-020-01739-z.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Fei Teng and Ju-Xiang Zhang contributed equally to this work.

Contributor Information

Zi-Ping Zhang, Email: zhang_zp@fudan.edu.cn.

Zhi-Qiu Hu, Email: huzq@fudan.edu.cn.

References

  • 1.Teng F, Zhang JX, Chang QM, et al. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:235. doi: 10.1186/s13046-020-01739-z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

13046_2023_2824_MOESM1_ESM.pdf (221.7KB, pdf)

Table S1. Primers and oligonucleotides sequences used in this study.


Articles from Journal of Experimental & Clinical Cancer Research : CR are provided here courtesy of BMC

RESOURCES